drugset / Trial / NCT00519649
Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to assess the persistence of immunity to hepatitis B in children who received three consecutive doses of HBV vaccine (EngerixTM-B) in infancy. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.
Timeline
- Start
- 2007-08-31
- Primary completion
- 2007-12-31
- Completion
- 2007-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Engerix™-B Kinder | Vaccine | — | Intramuscular |